重大事件
即時報告
8-K
2026-06-01
報告日期：2026年5月30日
AI 繁中摘要
📄 **申報類型：8-K（現行報告）**
📅 **報告日期：2026年5月30日**
🏢 **公司：Eikon Therapeutics, Inc.（CIK: 0001861123，生物製品行業）**
---
Eikon Therapeutics 於2026年6月1日向SEC提交了一份8-K表格，主要涉及以下三個項目：
- **Item 7.01：Regulation FD Disclosure（監管FD披露）**
- **Item 8.01：Other Events（其他事項）**
- **Item 9.01：Financial Statements and Exhibits（財務報表及附件）**
公司同時提交了兩份重要附件：
- **Exhibit 99.1** 及 **Exhibit 99.2**，內容應為相關披露材料的詳細說明或新聞稿。
此外，申報文件中包含大量圖表（GRAPHIC，共49張），可能為會議演示材料、臨床數據、研發進展或財務圖表。
---
### 📌 對投資者的潛在意義
由於8-K常用於披露重大非例行事件（如臨床試驗結果、監管里程碑、合作協議或公司戰略變更），加上本次申報涉及Regulation FD及「其他事項」，投資者應密切留意展品99.1及99.2的詳細內容。若涉及臨床數據或監管進展，可能對公司股價及市場預期產生直接影響。
👉 建議參考完整申報文件及附件，以掌握具體事件細節。
展開英文正文
EDGAR Filing Documents for 0001193125-26-249725 SEC.gov EDGAR Latest Filings Filings search tools Filing Detail SEC Home » Company Search » Current Page Form 8-K - Current report: SEC Accession No. 0001193125-26-249725 Filing Date 2026-06-01 Accepted 2026-06-01 07:30:25 Documents 60 Period of Report 2026-05-30 Items Item 7.01: Regulation FD Disclosure Item 8.01: Other Events Item 9.01: Financial Statements and Exhibits Interactive Data Document Format Files Seq Description Document Type Size 1 8-K eikn-20260530.htm iXBRL 8-K 50058 2 EX-99.1 eikn-ex99_1.htm EX-99.1 43536 3 EX-99.2 eikn-ex99_2.htm EX-99.2 45493 4 GRAPHIC eikn-ex99_1s1.jpg GRAPHIC 155739 5 GRAPHIC eikn-ex99_1s2.jpg GRAPHIC 628935 6 GRAPHIC eikn-ex99_1s3.jpg GRAPHIC 250603 7 GRAPHIC eikn-ex99_1s4.jpg GRAPHIC 444698 8 GRAPHIC eikn-ex99_1s5.jpg GRAPHIC 164966 9 GRAPHIC eikn-ex99_1s6.jpg GRAPHIC 435372 10 GRAPHIC eikn-ex99_1s7.jpg GRAPHIC 294866 11 GRAPHIC eikn-ex99_1s8.jpg GRAPHIC 358728 12 GRAPHIC eikn-ex99_1s9.jpg GRAPHIC 491901 13 GRAPHIC eikn-ex99_1s10.jpg GRAPHIC 398484 14 GRAPHIC eikn-ex99_1s11.jpg GRAPHIC 275795 15 GRAPHIC eikn-ex99_1s12.jpg GRAPHIC 282396 16 GRAPHIC eikn-ex99_1s13.jpg GRAPHIC 200905 17 GRAPHIC eikn-ex99_1s14.jpg GRAPHIC 434680 18 GRAPHIC eikn-ex99_1s15.jpg GRAPHIC 354215 19 GRAPHIC eikn-ex99_1s16.jpg GRAPHIC 387053 20 GRAPHIC eikn-ex99_1s17.jpg GRAPHIC 358667 21 GRAPHIC eikn-ex99_1s18.jpg GRAPHIC 437313 22 GRAPHIC eikn-ex99_1s19.jpg GRAPHIC 286839 23 GRAPHIC eikn-ex99_1s20.jpg GRAPHIC 188024 24 GRAPHIC eikn-ex99_1s21.jpg GRAPHIC 409673 25 GRAPHIC eikn-ex99_1s22.jpg GRAPHIC 457181 26 GRAPHIC eikn-ex99_1s23.jpg GRAPHIC 213047 27 GRAPHIC eikn-ex99_1s24.jpg GRAPHIC 684172 28 GRAPHIC eikn-ex99_1s25.jpg GRAPHIC 337543 29 GRAPHIC eikn-ex99_1s26.jpg GRAPHIC 520974 30 GRAPHIC eikn-ex99_1s27.jpg GRAPHIC 277958 31 GRAPHIC eikn-ex99_1s28.jpg GRAPHIC 150720 32 GRAPHIC eikn-ex99_1s29.jpg GRAPHIC 401762 33 GRAPHIC eikn-ex99_1s30.jpg GRAPHIC 246547 34 GRAPHIC eikn-ex99_1s31.jpg GRAPHIC 145126 35 GRAPHIC eikn-ex99_1s32.jpg GRAPHIC 414506 36 GRAPHIC eikn-ex99_1s33.jpg GRAPHIC 157434 37 GRAPHIC eikn-ex99_1s34.jpg GRAPHIC 337871 38 GRAPHIC eikn-ex99_1s35.jpg GRAPHIC 274802 39 GRAPHIC eikn-ex99_1s36.jpg GRAPHIC 137849 40 GRAPHIC eikn-ex99_1s37.jpg GRAPHIC 327296 41 GRAPHIC eikn-ex99_1s38.jpg GRAPHIC 415418 42 GRAPHIC eikn-ex99_1s39.jpg GRAPHIC 275605 43 GRAPHIC eikn-ex99_1s40.jpg GRAPHIC 184506 44 GRAPHIC eikn-ex99_1s41.jpg GRAPHIC 360991 45 GRAPHIC eikn-ex99_1s42.jpg GRAPHIC 403654 46 GRAPHIC eikn-ex99_1s43.jpg GRAPHIC 240584 47 GRAPHIC eikn-ex99_1s44.jpg GRAPHIC 328742 48 GRAPHIC eikn-ex99_1s45.jpg GRAPHIC 178031 49 GRAPHIC eikn-ex99_1s46.jpg GRAPHIC 295958 50 GRAPHIC eikn-ex99_1s47.jpg GRAPHIC 373908 51 GRAPHIC eikn-ex99_1s48.jpg GRAPHIC 312860 52 GRAPHIC eikn-ex99_1s49.jpg GRAPHIC 137815 Complete submission text file 0001193125-26-249725.txt 22097062 Data Files Seq Description Document Type Size 53 XBRL TAXONOMY EXTENSION SCHEMA WITH EMBEDDED LINKBASES DOCUMENT eikn-20260530.xsd EX-101.SCH 42837 63 EXTRACTED XBRL INSTANCE DOCUMENT eikn-20260530_htm.xml XML 5433 Mailing Address 230 HARRIET TUBMAN WAY MILLBRAE CA 94030 Business Address 230 HARRIET TUBMAN WAY MILLBRAE CA 94030 341-777-0566 Eikon Therapeutics, Inc. (Filer) CIK: 0001861123 (see all company filings) EIN.: 842807586 | State of Incorp.: DE | Fiscal Year End: 1231 Type: 8-K | Act: 34 | File No.: 001-43085 | Film No.: 261047171 SIC: 2836 Biological Products, (No Diagnostic Substances) (CF Office: 03 Life Sciences)